Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
PHASE2
This phase II/III trial studies how well daunorubicin and cytarabine with o...
Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
PHASE2
This study will treat participants with newly diagnosed, low, intermediate ...
Comparison of Quality of Life in Patients Undergoing More Intensive Versus Less Intensive Chemotherapy and Radiation Preceding a Bone Marrow Transplant
N/A
This study will examine the quality of life of patients undergoing bone mar...
Status
Completed
Location
Warren G. Magnuson Clinical Center (CC)
Start Date
1999-10
Trial ID
NCT00004994
Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD
PHASE2
The purpose of this research study is to see if people whose Acute myeloid ...